시장보고서
상품코드
1968165

유방 생검 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Breast Biopsy Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: | 리서치사: Value Market Research | 페이지 정보: 영문 138 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유방 생검 시장 규모는 2025년 8억 7,000만 달러에서 2034년에는 14억 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 5.33%로 성장할 전망입니다.

세계 유방암 환자가 증가함에 따라 세계 유방 생검 시장은 꾸준히 성장하고 있습니다. 암 조기발견과 정기검진 프로그램에 대한 인식 개선은 시장 확대를 지원하는 요인으로 작용하고 있습니다. 정부 및 의료기관에서 유방촬영술 및 진단검사를 장려하고 있는 것이 생검 시술 수요를 직접적으로 증가시키고 있습니다. 저침습 생검 기술, 영상 유도 시스템 등의 기술 발전도 시술의 안전성과 정확성을 높여 더 많은 환자들이 조기 진단을 선택하도록 돕고 있습니다.

본 시장의 주요 시장 성장 촉진요인으로는 고령층 여성 인구 증가, 생활습관 관련 위험요인, 개발도상국의 의료 인프라 개선 등을 들 수 있습니다. 진공흡입식 생검 시스템, 코어니들 생검 시스템 등 첨단 생검 기기는 통증 감소와 회복시간 단축으로 보급이 확대되고 있습니다. 병원과 진단센터에서는 검출 정확도 향상을 위해 더 나은 영상 기술에 대한 투자가 이루어지고 있습니다. 또한 선진국의 유리한 보험급여 정책은 환자들의 이러한 시술에 대한 접근을 돕고 있습니다.

향후 전망으로는 인공지능(AI)과 디지털 영상 솔루션의 통합으로 시장은 강력한 성장이 예상됩니다. AI를 활용한 영상 분석은 의사가 보다 정확하고 빠르게 이상 징후를 감지할 수 있도록 돕습니다. 신흥 국가에서는 의료에 대한 인식이 높아지고 의료비 지출이 증가함에 따라 새로운 성장 기회가 창출될 수 있습니다. 저침습적이고 신속한 진단 방법에 대한 지속적인 연구는 향후 수년간 시장 수요를 더욱 증가시킬 것입니다.

목차

제1장 서론

제2장 개요

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 유방 생검 시장 : 제품별

제5장 세계의 유방 생검 시장 : 영상 유도 기술별

제6장 세계의 유방 생검 시장 : 최종사용자별

제7장 세계의 유방 생검 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

KSA 26.03.25

The Breast Biopsy Market size is expected to reach USD 1.40 Billion in 2034 from USD 0.87 Billion (2025) growing at a CAGR of 5.33% during 2026-2034.

The Global Breast Biopsy Market is growing steadily due to the rising number of breast cancer cases worldwide. Increasing awareness about early cancer detection and regular screening programs is supporting market expansion. Governments and healthcare organizations are promoting mammography and diagnostic tests, which directly increases the demand for biopsy procedures. Technological advancements such as minimally invasive biopsy techniques and image-guided systems are also making procedures safer and more accurate, encouraging more patients to opt for early diagnosis.

The main drivers of this market include the growing female population in aging groups, lifestyle-related risk factors, and improved healthcare infrastructure in developing countries. Advanced biopsy devices like vacuum-assisted and core needle biopsy systems are gaining popularity because they reduce pain and recovery time. Hospitals and diagnostic centers are investing in better imaging technologies to improve detection accuracy. In addition, favorable reimbursement policies in developed regions are supporting patient access to these procedures.

Looking ahead, the market is expected to witness strong growth with the integration of artificial intelligence and digital imaging solutions. AI-powered imaging analysis can help doctors detect abnormalities more accurately and quickly. Emerging economies are likely to offer new growth opportunities as awareness and healthcare spending increase. Continuous research in less invasive and faster diagnostic methods will further boost market demand over the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Vacuum Assisted Biopsy
  • Core Needle Biopsy
  • Fine Needle Aspiration Biopsy

By Image Guided Technology

  • MRI Guided Breast Biopsy
  • Ultrasound Guided Breast Biopsy
  • Mammography Guided Stereotactic Biopsy
  • CT Guided Biopsy
  • Other Image Guided Breast Biopsy

By End User

  • Hospitals and Clinics
  • Diagnostic Centers

COMPANIES PROFILED

  • Ethicon Endo Surgery, Cook Medical Incorporated, Galini SRL, Hologic Inc, C R Bard Inc, Intact Medical Corporation, Becton and Dickinson Company, Argon Medical Devices, Encapsule medical Devices LLC, Leica Biosystems Nussloch GmbH
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BREAST BIOPSY MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Vacuum Assisted Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Core Needle Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Fine Needle Aspiration Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BREAST BIOPSY MARKET: BY IMAGE GUIDED TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Image Guided Technology
  • 5.2. MRI Guided Breast Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Ultrasound Guided Breast Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Mammography Guided Stereotactic Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. CT Guided Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Other Image Guided Breast Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BREAST BIOPSY MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BREAST BIOPSY MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Image Guided Technology
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Image Guided Technology
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Image Guided Technology
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Image Guided Technology
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Image Guided Technology
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BREAST BIOPSY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Ethicon Endo Surgery
    • 9.2.2 Cook Medical Incorporated
    • 9.2.3 Galini SRL
    • 9.2.4 Hologic Inc
    • 9.2.5 C. R. Bard Inc
    • 9.2.6 Intact Medical Corporation
    • 9.2.7 Becton And Dickinson Company
    • 9.2.8 Argon Medical Devices
    • 9.2.9 Encapsule Medical Devices LLC
    • 9.2.10 Leica Biosystems Nussloch GmbH
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제